The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) had its price target lowered by BTIG Research from $11.00 to $9.00 in a report released on Monday,Benzinga reports. The firm currently has a buy rating ...

Aldeyra Therapeutics, Inc.’s ALDX share price has surged by 23.94%, which has investors questioning if this is right time to sell.

School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China University of Chinese Academy of Sciences, ...

I asked Gemini about more than just the mechanics to see how the Deep Research report would do with multiple facets of a ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.

Every year, thousands of tons of brown algae are extracted from the seabed to obtain compounds such as alginates, a polymer ...

A chemical reaction that's vital to a range of commercial and industrial goods may soon be initiated more effectively and less expensively.

A research team studied how iridium and palladium nanoparticles can change the properties of catalysts with minor degradation ...

Just as a stylish wrap top or stretchy headband can accent your athletic endeavors (and look just as cool outside of a ...

A recent study has used advanced techniques to uncover the role of ultraviolet (UV) light in activating peracetic acid (PAA) to generate powerful radicals, essential for water treatment. By combining ...